132 related articles for article (PubMed ID: 9813625)
1. Crystallization and stone formation inside the nephron.
Kok DJ
Scanning Microsc; 1996; 10(2):471-84; discussion 484-6. PubMed ID: 9813625
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for crystallization in the nephron: the role of renal development.
Kok DJ; Schell-Feith EA
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S364-70. PubMed ID: 10541265
[TBL] [Abstract][Full Text] [Related]
3. Role of agglomeration in the early stages of papillar stone formation.
Söhnel O; Grases F; Garcia-Ferragut L
Scanning Microsc; 1994; 8(3):513-21; discussion 521-2. PubMed ID: 7747153
[TBL] [Abstract][Full Text] [Related]
4. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
5. Calcium oxalate nephrolithiasis, a free or fixed particle disease.
Kok DJ; Khan SR
Kidney Int; 1994 Sep; 46(3):847-54. PubMed ID: 7996806
[TBL] [Abstract][Full Text] [Related]
6. Kidney models of calcium oxalate stone formation.
Robertson WG
Nephron Physiol; 2004; 98(2):p21-30. PubMed ID: 15499211
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
[TBL] [Abstract][Full Text] [Related]
9. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
Sheng X; Ward MD; Wesson JA
J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
[TBL] [Abstract][Full Text] [Related]
10. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
Wesson JA; Worcester E
Scanning Microsc; 1996; 10(2):415-23; 423-4. PubMed ID: 9813620
[TBL] [Abstract][Full Text] [Related]
11. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells.
Lieske JC; Deganello S
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S422-9. PubMed ID: 10541277
[TBL] [Abstract][Full Text] [Related]
12. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
13. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
14. Impact of various modifiers on calcium oxalate crystallization.
Kulaksizoglu S; Sofikerim M; Cevik C
Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
[TBL] [Abstract][Full Text] [Related]
15. Crystallization during volume reduction of solutions with an ion-composition corresponding to that in the distal tubuli.
Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
Scanning Microsc; 1996; 10(2):487-97; discussion 497-8. PubMed ID: 9813626
[TBL] [Abstract][Full Text] [Related]
16. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
17. Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
Lieske JC; Hammes MS; Toback FG
Scanning Microsc; 1996; 10(2):519-33; discussion 533-4. PubMed ID: 9813629
[TBL] [Abstract][Full Text] [Related]
18. Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients.
He JY; Deng SP; Ouyang JM
IEEE Trans Nanobioscience; 2010 Jun; 9(2):156-63. PubMed ID: 20423812
[TBL] [Abstract][Full Text] [Related]
19. How does bovine serum albumin prevent the formation of kidney stone? A kinetics study.
Liu J; Jiang H; Liu XY
J Phys Chem B; 2006 May; 110(18):9085-9. PubMed ID: 16671718
[TBL] [Abstract][Full Text] [Related]
20. Reverse engineering the kidney: modelling calcium oxalate monohydrate crystallization in the nephron.
Borissova A; Goltz GE; Kavanagh JP; Wilkins TA
Med Biol Eng Comput; 2010 Jul; 48(7):649-59. PubMed ID: 20424925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
